Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Q Lacy

Showing results (31-40 of 142) with videos related to

Pageof 15
Sort By:
The New England Journal of Medicine|April 24, 1997
A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicineR A Kyle, M A Gertz, P R Greipp, et al.
Leukemia|April 29, 1998
Contrast in cytokine expression between patients with monoclonal gammopathy of undetermined significance or multiple myelomaK A Donovan, M Q Lacy, M P Kline, et al.
Bone Marrow Transplantation|December 26, 2001
Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemiaS Kumar, M G Chen, D A Gastineau, et al.
Blood Cancer Journal|September 10, 2013
Pomalidomide: the new immunomodulatory agent for the treatment of multiple myelomaA A Chanan-Khan, A Swaika, A Paulus, et al.
Leukemia|September 13, 2003
Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemiaS Kumar, M G Chen, D A Gastineau, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 16, 2011
Trend toward improved day 100 and two-year survival following stem cell transplantation for AL: a comparison before and after 2006M A Gertz, M Q Lacy, A Dispenzieri, et al.
Leukemia|October 24, 2013
Long-term response to lenalidomide in patients with newly diagnosed multiple myelomaT V Kourelis, S K Kumar, G Srivastava, et al.
Bone Marrow Transplantation|December 2, 2000
Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL)M A Gertz, M Q Lacy, D A Gastineau, et al.
Cancer Genetics and Cytogenetics|August 25, 1999
Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myelomaS V Rajkumar, R Fonseca, G W Dewald, et al.
Bone Marrow Transplantation|July 16, 2008
Autologous HSC transplant in t-MDS/AML using cells harvested prior to the development of the secondary malignancyL J Costa, V Rodriguez, L F Porrata, et al.
Pageof 15

Showing results (31-40 of 142) with videos related to

Sort By:
Pageof 15
The New England Journal of Medicine|April 24, 1997
A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicineR A Kyle, M A Gertz, P R Greipp, et al.
Leukemia|April 29, 1998
Contrast in cytokine expression between patients with monoclonal gammopathy of undetermined significance or multiple myelomaK A Donovan, M Q Lacy, M P Kline, et al.
Bone Marrow Transplantation|December 26, 2001
Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemiaS Kumar, M G Chen, D A Gastineau, et al.
Blood Cancer Journal|September 10, 2013
Pomalidomide: the new immunomodulatory agent for the treatment of multiple myelomaA A Chanan-Khan, A Swaika, A Paulus, et al.
Leukemia|September 13, 2003
Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemiaS Kumar, M G Chen, D A Gastineau, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 16, 2011
Trend toward improved day 100 and two-year survival following stem cell transplantation for AL: a comparison before and after 2006M A Gertz, M Q Lacy, A Dispenzieri, et al.
Leukemia|October 24, 2013
Long-term response to lenalidomide in patients with newly diagnosed multiple myelomaT V Kourelis, S K Kumar, G Srivastava, et al.
Bone Marrow Transplantation|December 2, 2000
Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL)M A Gertz, M Q Lacy, D A Gastineau, et al.
Cancer Genetics and Cytogenetics|August 25, 1999
Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myelomaS V Rajkumar, R Fonseca, G W Dewald, et al.
Bone Marrow Transplantation|July 16, 2008
Autologous HSC transplant in t-MDS/AML using cells harvested prior to the development of the secondary malignancyL J Costa, V Rodriguez, L F Porrata, et al.
Pageof 15